CAS
IBB icon

Coppell Advisory Solutions’s iShares Biotechnology ETF IBB Stock Holding History

Coppell Advisory Solutions’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-59
Closed -$7.77K – 1026
2024
Q4 		$7.77K Hold
59
– – ﹤0.01% 1202
2024
Q3 		$8.55K Buy
59
+15
+34% +$2.17K ﹤0.01% 1130
2024
Q2 		$6.07K Buy
+44
New +$5.87K ﹤0.01% 1155
2023
Q4 		$14.7K Buy
108
+84
+350% +$10.2K ﹤0.01% 833
2023
Q3 		$3.16K Hold
24
– – ﹤0.01% 795
2023
Q2 		$3.04K Buy
+24
New +$3.12K ﹤0.01% 953
2023
Q1 		– Sell
-24
Closed -$3.16K – 615
2022
Q4 		$3.16K Buy
+24
New +$3.1K ﹤0.01% 797

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Coppell Advisory Solutions's IBB Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 59 shares — an estimated $7.77K sold.

Coppell Advisory Solutions first reported a position in IBB in Q4 2022 and held it in 7 quarters. The position peaked at $14.7K in Q4 2023. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 59 iShares Biotechnology ETF shares in Q1 2025, an estimated $7.77K.
  • Coppell Advisory Solutions first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 7 quarters.
  • Coppell Advisory Solutions's iShares Biotechnology ETF position peaked at $14.7K in Q4 2023.
  • 831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.